A Novel Subtype of Myeloproliferative Neoplasms Driven by a MYC-Alarmin AxisNicole D. Vincelette(Moffitt Cancer Center), Seongseok Yun(Moffitt Cancer Center)bioRxiv (Cold Spring Harbor Laboratory)September 26, 202310.1101/2023.09.25.559138Cited by 1SaveCiteExport RISWatch citationsRelated PapersMutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk <i>NPM1</i>-mutated AML|Blood Advances|2024|31The Prognostic Impact of <i>FLT3</i> in <i>NPM1</i>-Mutated AML: Co-Occurrence of <i>FLT3-ITD</i> and <i>FLT3-TKD</i> Confers Poor Outcomes|Blood|2022|2Secondary AML Mutations Confer Poor Prognosis in Patients with ELN Favorable Risk <i>NPM1</i>-Mutated AML|Blood|2022|2